Marshall E. Kadin, MD | Authors

Current Management of Primary Cutaneous CD30+ T-cell Lymphoproliferative Disorders

November 30, 2009

The purpose of this review is to familiarize oncologists with the clinical and pathologic features of this relatively rare disease spectrum. This should enable appropriate clinical management and reassurance of patients concerned about their prognosis.